ConductScience.org, home

Paper19757204

Down-regulation synaptic vesicle protein 2A in the anterior temporal neocortex of patients with intractable epilepsy.

Feng G and 7 others. J Mol Neurosci, 2009. Cited by 62 papers, by iCite.

Cite this record

ConductScience Library. Down-regulation synaptic vesicle protein 2A in the anterior temporal neocortex of patients with intractable epilepsy. Papers, record 19757204. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19757204

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Down-regulation synaptic vesicle protein 2A in the anterior temporal neocortex of patients with intractable epilepsy.
PubMed
Journal
J Mol Neurosci
PubMed
Year
2009
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
62
iCite
Relative citation ratio, by iCite
1.66
iCite
Revised in PubMed
2021-10-20
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Feng GGuibo
2Xiao FFei
3Lu YYang
4Huang ZZuchun
5Yuan JJie
6Xiao ZZheng
7Xi ZZhiqin
8Wang XXuefeng

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Down-RegulationMajor topic
EpilepsyMajor topic
Membrane GlycoproteinsMajor topic
NeocortexMajor topic
Nerve Tissue ProteinsMajor topic
Temporal LobeMajor topic
Adolescent
Adult
Biomarkers
Blotting, Western
Female
Fluorescent Antibody Technique
Humans
Immunochemistry
Male
Middle Aged
Neurons
Young Adult

Source PubMed

Download CSV of topics

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115946327Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms.Epilepsia2005https://conductscience.org/library/papers/15946327PubMed
212644749Mechanisms of antiepileptic drug resistance.Curr Opin Neurol2003https://conductscience.org/library/papers/12644749PubMed
318717715Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy.Epilepsia2009https://conductscience.org/library/papers/18717715PubMed
419220410Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers.Epilepsia2009https://conductscience.org/library/papers/19220410PubMed
519176798SV2 renders primed synaptic vesicles competent for Ca2+ -induced exocytosis.J Neurosci2009https://conductscience.org/library/papers/19176798PubMed
615210974The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam.Proc Natl Acad Sci U S A2004https://conductscience.org/library/papers/15210974PubMed
710624962SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release.Neuron1999https://conductscience.org/library/papers/10624962PubMed
817199025Seletracetam (UCB 44212).Neurotherapeutics2007https://conductscience.org/library/papers/17199025PubMed
910660394Early identification of refractory epilepsy.N Engl J Med2000https://conductscience.org/library/papers/10660394PubMed
1017199019Brivaracetam (UCB 34714).Neurotherapeutics2007https://conductscience.org/library/papers/17199019PubMed
1115208697The neurobiology of antiepileptic drugs.Nat Rev Neurosci2004https://conductscience.org/library/papers/15208697PubMed
128083732Differential expression of synaptic vesicle protein 2 (SV2) isoforms.J Neurosci1994https://conductscience.org/library/papers/8083732PubMed
1318779938Altered expression of synaptotagmin I in temporal lobe tissue of patients with refractory epilepsy.J Mol Neurosci2009https://conductscience.org/library/papers/18779938PubMed
1410611374Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A).Proc Natl Acad Sci U S A1999https://conductscience.org/library/papers/10611374PubMed
152579958Identification of a transmembrane glycoprotein specific for secretory vesicles of neural and endocrine cells.J Cell Biol1985https://conductscience.org/library/papers/2579958PubMed
1616556440Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein.Eur J Pharmacol2006https://conductscience.org/library/papers/16556440PubMed
172233919The evaluation and treatment of seizures.N Engl J Med1990https://conductscience.org/library/papers/2233919PubMed
1810210025Clinical aspects and biological bases of drug-resistant epilepsies.Epilepsy Res1999https://conductscience.org/library/papers/10210025PubMed
1910625067SV2C is a synaptic vesicle protein with an unusually restricted localization: anatomy of a synaptic vesicle protein family.Neuroscience1999https://conductscience.org/library/papers/10625067PubMed

Download CSV of references

Cited by36

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.

PMIDTitleJournalYearIn PapersSource
41528802Higher drinking frequency corresponds to lower synaptic density in people with alcohol use disorder.J Clin Invest2026https://conductscience.org/library/papers/41528802PubMed
40878444Targeting ROCK2 to Restore Epileptic Synaptic Networks via Mitophagy Activation: Insights from Translational Imaging of SV2A In Vivo.Adv Sci (Weinh)2025https://conductscience.org/library/papers/40878444PubMed
40016536Single-Cell Analysis of Sex and Gender Differences in the Human Brain During Development and Disease.Cell Mol Neurobiol2025https://conductscience.org/library/papers/40016536PubMed
39777496Transcriptionally downregulated GABAergic genes associated with synaptic density network dysfunction in temporal lobe epilepsy.Eur J Nucl Med Mol Imaging2025https://conductscience.org/library/papers/39777496PubMed
36313347Antiseizure medication in early nervous system development. Ion channels and synaptic proteins as principal targets.Front Pharmacol2022https://conductscience.org/library/papers/36313347PubMed
35686059Connectivity Mapping Using a Novel sv2a Loss-of-Function Zebrafish Epilepsy Model as a Powerful Strategy for Anti-epileptic Drug Discovery.Front Mol Neurosci2022https://conductscience.org/library/papers/35686059PubMed
35578248Expression profile of synaptic vesicle glycoprotein 2A, B, and C paralogues in temporal neocortex tissue from patients with temporal lobe epilepsy (TLE).Mol Brain2022https://conductscience.org/library/papers/35578248PubMed
35573314Synaptic Vesicle Glycoprotein 2A: Features and Functions.Front Neurosci2022https://conductscience.org/library/papers/35573314PubMed
34435329Reductions in Synaptic Vesicle Glycoprotein 2 Isoforms in the Cortex and Hippocampus in a Rat Model of Traumatic Brain Injury.Mol Neurobiol2021https://conductscience.org/library/papers/34435329PubMed
33922424Synaptic Vesicle Protein 2A Expression in Glutamatergic Terminals Is Associated with the Response to Levetiracetam Treatment.Brain Sci2021https://conductscience.org/library/papers/33922424PubMed
32514885Preclinical PET Studies of [11C]UCB-J Binding in Minipig Brain.Mol Imaging Biol2020https://conductscience.org/library/papers/32514885PubMed
32206990Exploring with [18F]UCB-H the in vivo Variations in SV2A Expression through the Kainic Acid Rat Model of Temporal Lobe Epilepsy.Mol Imaging Biol2020https://conductscience.org/library/papers/32206990PubMed
31818018Synaptic Pruning by Microglia in Epilepsy.J Clin Med2019https://conductscience.org/library/papers/31818018PubMed
31659510Current radiotracers to image neurodegenerative diseases.EJNMMI Radiopharm Chem2019https://conductscience.org/library/papers/31659510PubMed
31394034The Synaptic Vesicle Glycoprotein 2: Structure, Function, and Disease Relevance.ACS Chem Neurosci2019https://conductscience.org/library/papers/31394034PubMed
31209780Validation of Parametric Methods for [11C]UCB-J PET Imaging Using Subcortical White Matter as Reference Tissue.Mol Imaging Biol2020https://conductscience.org/library/papers/31209780PubMed
31175396Synthesis and in vivo evaluation of [18F]UCB-J for PET imaging of synaptic vesicle glycoprotein 2A (SV2A).Eur J Nucl Med Mol Imaging2019https://conductscience.org/library/papers/31175396PubMed
31166988Anxiety-like features and spatial memory problems as a consequence of hippocampal SV2A expression.PLoS One2019https://conductscience.org/library/papers/31166988PubMed
30949562Sex differences in stress-related alcohol use.Neurobiol Stress2019https://conductscience.org/library/papers/30949562PubMed
30121895Quantifying SV2A density and drug occupancy in the human brain using [11C]UCB-J PET imaging and subcortical white matter as reference tissue.Eur J Nucl Med Mol Imaging2019https://conductscience.org/library/papers/30121895PubMed

See all 36 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SV2A9900PubTator's text mininghttps://conductscience.org/library/genes/9900

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19757204

GET https://conductscience.org/api/papers/v1/19757204/cited_by?page=2